Bangladeshi patient undergoes complex skull-base tumour surgery in Foshan
Foshan Fosun Chancheng Hospital reports nearly 20 hours of surgery for a glomus jugulare tumour, with hearing at baseline three weeks later.
Published by CareAtlas · Editorial policy
A Bangladeshi patient named Zakir underwent nearly 20 hours of surgery at Foshan Fosun Chancheng Hospital for an extensive glomus jugulare tumour. Three weeks later, his hearing remained at its preoperative level, his pre-existing mild facial weakness had resolved and his headaches had disappeared, according to the hospital network’s account.
Communication before travelling to China
Zakir was diagnosed with a left-sided glomus jugulare tumour in Bangladesh about a year earlier. Local doctors considered the surgical risks difficult to manage there and advised treatment abroad. His family considered Thailand, Singapore and India before learning about the Foshan team.
He had never visited China and was concerned about a major operation in an unfamiliar healthcare system. Several rounds of communication with the medical team preceded his journey to Foshan.
Planning across five specialties
The tumour extended through the skull base, temporal bone and upper neck and involved the dura mater. It lay close to the internal carotid artery, with the facial nerve running through the affected area and the auditory nerve nearby.
The highly vascular tumour posed risks of major bleeding, facial paralysis and hearing loss. Ear, nose and throat surgery, vascular surgery, neurosurgery, radiology and anaesthesiology specialists assessed the case together and prepared contingency plans for each stage.
Four chief physicians took part in the operation: Mei Xiaofeng, Du Guoneng, Chen Baozhong and Zheng Ligang.
Overnight operation and discharge assessment
Surgery began at 10 a.m. on August 6, 2026, and finished at about 5 a.m. on August 7. The team followed a sequence of protection, dissection, resection and reconstruction: identifying and protecting critical vessels and nerves, separating the tumour, then performing total temporal bone resection for removal. Dural repair and reconstruction followed.
The hospital reported complete tumour removal and no blood transfusion during the procedure. At the three-week assessment, hearing was at baseline and the facial weakness present before surgery had completely resolved.
On August 27, specialists from the three surgical departments reviewed his recovery on the ward and provided discharge and rehabilitation instructions before his planned journey home.